These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Long-acting injectable risperidone: safety and efficacy in stable patients switched from conventional depot antipsychotics. Turner M; Eerdekens E; Jacko M; Eerdekens M Int Clin Psychopharmacol; 2004 Jul; 19(4):241-9. PubMed ID: 15201572 [TBL] [Abstract][Full Text] [Related]
25. Maintenance treatment with risperidone or low-dose haloperidol in first-episode schizophrenia: 1-year results of a randomized controlled trial within the German Research Network on Schizophrenia. Gaebel W; Riesbeck M; Wölwer W; Klimke A; Eickhoff M; von Wilmsdorff M; Jockers-Scherübl MC; Kühn KU; Lemke M; Bechdolf A; Bender S; Degner D; Schlösser R; Schmidt LG; Schmitt A; Jäger M; Buchkremer G; Falkai P; Klingberg S; Köpcke W; Maier W; Häfner H; Ohmann C; Salize HJ; Schneider F; Möller HJ; J Clin Psychiatry; 2007 Nov; 68(11):1763-74. PubMed ID: 18052570 [TBL] [Abstract][Full Text] [Related]
26. Frequency of sexual dysfunction and other reproductive side-effects in patients with schizophrenia treated with risperidone, olanzapine, quetiapine, or haloperidol: the results of the EIRE study. Bobes J; Garc A-Portilla MP; Rejas J; Hern Ndez G; Garcia-Garcia M; Rico-Villademoros F; Porras A J Sex Marital Ther; 2003; 29(2):125-47. PubMed ID: 12623765 [TBL] [Abstract][Full Text] [Related]
27. Olanzapine: an updated review of its use in the management of schizophrenia. Bhana N; Foster RH; Olney R; Plosker GL Drugs; 2001; 61(1):111-61. PubMed ID: 11217867 [TBL] [Abstract][Full Text] [Related]
28. [A new pharmacological strategy for schizophrenia: the partial agonists of D2 dopaminergic receptors. The principle characteristics of aripiprazole]. Costentin J Encephale; 2009 Feb; 35(1):66-72. PubMed ID: 19250996 [TBL] [Abstract][Full Text] [Related]
29. New generation antipsychotics for first episode schizophrenia. Rummel C; Hamann J; Kissling W; Leucht S Cochrane Database Syst Rev; 2003; (4):CD004410. PubMed ID: 14584012 [TBL] [Abstract][Full Text] [Related]
30. Effects of atypical antipsychotics on the syndromal profile in treatment-resistant schizophrenia. Lindenmayer JP; Czobor P; Volavka J; Lieberman JA; Citrome L; Sheitman B; McEvoy JP; Cooper TB; Chakos M J Clin Psychiatry; 2004 Apr; 65(4):551-6. PubMed ID: 15119920 [TBL] [Abstract][Full Text] [Related]
31. [Metabolic side effects of risperidone in early onset schizophrenia]. Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267 [TBL] [Abstract][Full Text] [Related]
32. Maximizing response to first-line antipsychotics in schizophrenia: a review focused on finding from meta-analysis. Smith RC; Leucht S; Davis JM Psychopharmacology (Berl); 2019 Feb; 236(2):545-559. PubMed ID: 30506237 [TBL] [Abstract][Full Text] [Related]
33. Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine. Tada M; Shirakawa K; Matsuoka N; Mutoh S Psychopharmacology (Berl); 2004 Oct; 176(1):94-100. PubMed ID: 15083255 [TBL] [Abstract][Full Text] [Related]
34. Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol. Dossenbach M; Erol A; el Mahfoud Kessaci M; Shaheen MO; Sunbol MM; Boland J; Hodge A; O'Halloran RA; Bitter I; J Clin Psychiatry; 2004 Mar; 65(3):312-21. PubMed ID: 15096069 [TBL] [Abstract][Full Text] [Related]
36. [Comparative effectiveness of flupenthixol and risperidone on negative symptoms of schizophrenia]. Philipp M; Lesch OM; Schmauss M; Dose M; Glaser T Psychiatr Prax; 2003 May; 30 Suppl 2():S94-6. PubMed ID: 14509050 [TBL] [Abstract][Full Text] [Related]
37. An open, randomized, comparative study of efficacy and safety of risperidone and haloperidol in schizophrenia. Tamrakar SM; Nepal MK; Koirala NR; Sharma VD; Gurung CK; Adhikari SR Kathmandu Univ Med J (KUMJ); 2006; 4(2):152-60. PubMed ID: 18603890 [TBL] [Abstract][Full Text] [Related]
38. Amisulpride, an unusual "atypical" antipsychotic: a meta-analysis of randomized controlled trials. Leucht S; Pitschel-Walz G; Engel RR; Kissling W Am J Psychiatry; 2002 Feb; 159(2):180-90. PubMed ID: 11823257 [TBL] [Abstract][Full Text] [Related]
40. Drug treatment of the negative symptoms of schizophrenia. King DJ Eur Neuropsychopharmacol; 1998 Feb; 8(1):33-42. PubMed ID: 9452938 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]